Active Shortage

KETOROLAC TROMETHAMINE INJECTION, USP

FRESENIUS KABI CANADA LTD

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of KETOROLAC TROMETHAMINE INJECTION, USP in Canada?

Yes. KETOROLAC TROMETHAMINE INJECTION, USP 30MG has an active shortage reported to Health Canada (last updated August 11, 2026).

Why is KETOROLAC TROMETHAMINE INJECTION, USP not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will KETOROLAC TROMETHAMINE INJECTION, USP be available again?

The manufacturer's estimated resolution date is September 30, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file6 products

Expected resolution~2 days remaining (estimate)

Affected strength30MG

Last updated2026-08-11

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

TORADOL IM 30MG/ML

HOFFMANN-LA ROCHE LIMITED

30MG · DIN 02162652

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

KETOROLAC TROMETHAMINE INJECTION, USP

JUNO PHARMA CANADA INC.

30MG · DIN 02443376

Same strengthDifferent dosage formSame routeNo current shortage

Compare these two →

TORADOL INJ 10MG/ML

SYNTEX INC.

10MG · DIN 00882909

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

TORADOL IM

ATNAHS PHARMA UK LIMITED

10MG · DIN 02162644

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

KETOROLAC TROMETHAMINE INJECTION USP

SABEX INC

10MG · DIN 02239943

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

ACULAR

ABBVIE CORPORATION

0.5% · DIN 01968300

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Estimated Resolution

2026-09-30

~2 days remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

DIN

02244947

Strength

30MG

Dosage Form

LIQUID

Route

INTRAMUSCULAR

Active Ingredient

KETOROLAC TROMETHAMINE

Tier

Unrated

Last Updated

2026-08-11

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from FRESENIUS KABI CANADA LTD

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

0.9% SODIUM CHLORIDE INJECTION

900MG · DIN 02395150

2% CALCIUM GLUCONATE IN SODIUM CHLORIDE INJECTION

20MG · DIN 02538644

5% DEXTROSE INJECTION

50MG · DIN 02403536

ACYCLOVIR SODIUM INJECTION

50MG · DIN 02236926

ADDNUTRIV

DIN 02497697

ADENOSINE INJECTION

3MG · DIN 02457482